Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
China
· Delayed Price · Currency is CNY 90.62
+0.76 (0.85%)
Mar 12, 2025, 3:00 PM CST
SHA:688050 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Operating Revenue | 1,410 | 947.42 | 575.86 | 431.2 | 272.62 | Upgrade
|
| Other Revenue | - | 3.75 | 3.64 | 1.87 | 0.43 | Upgrade
|
| Revenue | 1,410 | 951.18 | 579.5 | 433.07 | 273.05 | Upgrade
|
| Revenue Growth (YoY) | 48.22% | 64.14% | 33.81% | 58.61% | 39.88% | Upgrade
|
| Cost of Revenue | - | 226.89 | 88.35 | 68.08 | 43.97 | Upgrade
|
| Gross Profit | 1,410 | 724.28 | 491.15 | 364.99 | 229.08 | Upgrade
|
| Selling, General & Admin | - | 300.08 | 178.57 | 142.27 | 96.03 | Upgrade
|
| Research & Development | - | 91.95 | 63.9 | 51.91 | 29.99 | Upgrade
|
| Other Operating Expenses | 978.28 | 14.98 | 8.69 | 7.17 | 3.97 | Upgrade
|
| Operating Expenses | 978.28 | 416.13 | 259.52 | 207.1 | 132.01 | Upgrade
|
| Operating Income | 431.53 | 308.16 | 231.62 | 157.89 | 97.06 | Upgrade
|
| Interest Expense | - | -9.81 | -2.02 | -0.74 | - | Upgrade
|
| Interest & Investment Income | - | 19.98 | 21.97 | 25.56 | 10.55 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.62 | -0.23 | -0.92 | 0.42 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.82 | -0.19 | -0.52 | -0.15 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | 429.71 | 318.75 | 250.81 | 181.65 | 107.96 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -1.84 | 1.49 | 0.2 | 0.28 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.11 | 0.01 | 0.02 | -0.15 | Upgrade
|
| Other Unusual Items | - | 10.65 | 11.77 | 5.9 | 2.95 | Upgrade
|
| Pretax Income | 429.71 | 327.67 | 264.08 | 187.77 | 111.04 | Upgrade
|
| Income Tax Expense | 42.55 | 41.62 | 36.85 | 20.01 | 14.92 | Upgrade
|
| Earnings From Continuing Operations | 387.16 | 286.05 | 227.23 | 167.75 | 96.12 | Upgrade
|
| Minority Interest in Earnings | - | 17.93 | 5.46 | 3.59 | 0.44 | Upgrade
|
| Net Income | 387.16 | 303.98 | 232.69 | 171.34 | 96.56 | Upgrade
|
| Net Income to Common | 387.16 | 303.98 | 232.69 | 171.34 | 96.56 | Upgrade
|
| Net Income Growth | 27.36% | 30.63% | 35.80% | 77.45% | 44.80% | Upgrade
|
| Shares Outstanding (Basic) | 190 | 189 | 190 | 189 | 161 | Upgrade
|
| Shares Outstanding (Diluted) | 190 | 190 | 190 | 189 | 161 | Upgrade
|
| Shares Change (YoY) | -0.11% | 0.25% | 0.17% | 17.57% | 13.96% | Upgrade
|
| EPS (Basic) | 2.04 | 1.61 | 1.23 | 0.91 | 0.60 | Upgrade
|
| EPS (Diluted) | 2.04 | 1.60 | 1.23 | 0.91 | 0.60 | Upgrade
|
| EPS Growth | 27.50% | 30.31% | 35.58% | 50.93% | 27.06% | Upgrade
|
| Free Cash Flow | - | -157.72 | -20.9 | -91.92 | 4.62 | Upgrade
|
| Free Cash Flow Per Share | - | -0.83 | -0.11 | -0.49 | 0.03 | Upgrade
|
| Dividend Per Share | - | 0.272 | 0.283 | 0.206 | 0.156 | Upgrade
|
| Dividend Growth | - | -3.92% | 37.79% | 32.13% | - | Upgrade
|
| Gross Margin | 100.00% | 76.15% | 84.75% | 84.28% | 83.90% | Upgrade
|
| Operating Margin | 30.61% | 32.40% | 39.97% | 36.46% | 35.55% | Upgrade
|
| Profit Margin | 27.46% | 31.96% | 40.15% | 39.56% | 35.36% | Upgrade
|
| Free Cash Flow Margin | - | -16.58% | -3.61% | -21.23% | 1.69% | Upgrade
|
| EBITDA | 502.65 | 379.28 | 271.42 | 188.07 | 123.73 | Upgrade
|
| EBITDA Margin | 35.65% | 39.87% | 46.84% | 43.43% | 45.31% | Upgrade
|
| D&A For EBITDA | 71.12 | 71.12 | 39.79 | 30.18 | 26.67 | Upgrade
|
| EBIT | 431.53 | 308.16 | 231.62 | 157.89 | 97.06 | Upgrade
|
| EBIT Margin | 30.61% | 32.40% | 39.97% | 36.46% | 35.55% | Upgrade
|
| Effective Tax Rate | 9.90% | 12.70% | 13.95% | 10.66% | 13.44% | Upgrade
|
| Revenue as Reported | - | 951.18 | 579.5 | 433.07 | 273.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.